Close
Nordic 9Nordic 9

Pioneer Group (investor - Accelerator)

United Kingdom
See something wrong or missing? Let us know
Offices:Nottingham

Pioneer Group (formerly BioCity) is the UK's largest life science incubation business,

Average round investment:3.66M USD
Average number per year:1.5
Distribution: 2026 (1)2025 (1)2023 (3)2021 (1)
Portfolio companies: United Kingdom NuVision BiotherapiesUnited Kingdom ImmuONEUnited Kingdom NunaBio See the entire list
Mostly invests in: United Kingdom United Kingdom (6) Biotech (6)
See the entire list

Showing 3 of 6 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Pioneer Group mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Pioneer Group

Name Criteria
Germany Miele Group
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Next Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Tom Latchford
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Investing Women Angels
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom HERmesa
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Switzerland Sangha Capital
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Key Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Two Magnolias
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Deep Science Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Finland Mikko Silventola
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Top